No connection

Search Results

XOSWW

BEARISH
$0.0 Live
Xos, Inc. · NASDAQ
$0.0 52W Range $0.0

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 24, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
The deterministic health profile is critically weak, headlined by a Piotroski F-Score of 2/9, indicating severe financial instability. Fundamental valuation metrics including the Graham Number and Intrinsic Value are unavailable, reflecting a lack of positive earnings or stable book value. A catastrophic Q/Q revenue decline of -54.51% combined with a near-zero share price ($0.0038) suggests a company in deep distress. The asset, being a warrant (XOSWW), is currently trading as a speculative instrument with no fundamental support.

Key Strengths

Maintains current SEC filing compliance (10-K submitted March 2026)
Extremely low nominal entry price for speculative gambling
Existence of a public reporting structure

Key Risks

Severe financial distress indicated by Piotroski F-Score of 2/9
Rapid revenue collapse with Q/Q growth at -54.51%
Total lack of liquidity and bearish technical trend (0/100)
High probability of warrant expiration worthless
Absence of institutional support or analyst coverage

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
6
Weak
Value
0
Future
5
Past
10
Health
15
Dividend
0
AI Verdict
Distressed/Speculative
Key drivers: Piotroski F-Score 2/9, Revenue contraction of -54.51%, Near-zero market price
Confidence
90%
Value
0/100

Lack of earnings makes traditional valuation formulas inapplicable.

Positives
No standout positives identified.
Watchpoints
  • No P/E or PEG available
  • Graham Number unavailable
  • Price/Book at 0.00
Future
5/100

Revenue growth is trending sharply negative.

Positives
No standout positives identified.
Watchpoints
  • Severe Q/Q revenue decline
  • Bearish technical trend
Past
10/100

Long-term price erosion with no recovery signs.

Positives
No standout positives identified.
Watchpoints
  • Consistent -5% performance across 1Y, 3Y, and 5Y horizons
Health
15/100

F-Score indicates failure in most financial health categories.

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 2/9 (Weak)
  • No Altman Z-Score available to confirm solvency
Dividend
0/100

Company is not in a position to return capital.

Positives
No standout positives identified.
Watchpoints
  • Zero dividend yield
  • Zero dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.0

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for XOSWW and closest competitors.

Updated 2026-04-23
XOS
Xos, Inc.
Primary
5Y
-5.0%
3Y
-5.0%
1Y
-5.0%
6M
-5.0%
1M
0.0%
1W
0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.0
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth -54.51%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
-50.5%
Op. Margin
-186.6%
Net Margin
-186.8%
Total Assets
$0.1B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
1.59x
Operating CF
$0.0B
Free Cash Flow
$0.0B
FCF Yield
100%

Ownership Structure

Institutional and insider holdings breakdown

Ownership Breakdown

Top Institutional Holders

Davidson Kempner Capital Management LP
466,666 shares • 2025-09-30
JPMORGAN CHASE & CO
266,664 shares • 2025-09-30
LMR Partners LLP
249,820 shares • 2025-09-30
Susquehanna International Group, LLP
213,261 shares • 2025-09-30
Jane Street Group, LLC
116,000 shares • 2025-09-30
Vestcor Inc
62,598 shares • 2025-09-30
Two Sigma Securities, LLC
29,334 shares • 2025-09-30
Wolverine Asset Management, LLC
21,817 shares • 2025-12-31

SEC Filings

Recent regulatory filings from the SEC EDGAR database

10-K
10-K
2026-03-30

XOSWW submitted its annual 10-K filing on March 30, 2026, which includes detailed disclosures on its business operations and financial condition. The report provides management's analysis of results of operations and outlines the company's specific risk factors.

8-K
8-K
2026-03-26
10-Q
10-Q
2025-11-13

XOSWW filed its quarterly 10-Q report on November 13, 2025. The provided excerpt indicates the inclusion of a Risk Factors section, although specific financial highlights and detailed risk descriptions were not available in the provided text.

8-K
8-K
2025-11-13
8-K
8-K
2025-08-27
8-K
8-K
2025-08-22
8-K
8-K
2025-08-14
8-K
CURRENT REPORT
2025-08-14
10-Q
10-Q
2025-08-13

XOSWW filed its quarterly 10-Q report on August 13, 2025. While the filing includes a dedicated section for risk factors, no specific financial highlights or detailed risk descriptions were provided in the available excerpts.

8-K
8-K
2025-08-13

Xos, Inc. filed an 8-K likely announcing its second-quarter 2025 financial results.

8-K
8-K
2025-06-27
10-Q
10-Q
2025-05-15
8-K
8-K
2025-05-14
8-K
8-K
2025-05-12
DEF 14A
DEF 14A
2025-05-12
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning XOSWW from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile